
Abbott brings ‘world’s first’ dual-chamber leadless pacemaker to the UK
The company says the minimally invasive system is set to ‘revolutionise’ care for patients as it allows for two separate devices to communicate for the first time.
The company says the minimally invasive system is set to ‘revolutionise’ care for patients as it allows for two separate devices to communicate for the first time.
For the first time, neuroscientists have developed a way to address debilitating PMS and menstrual pain symptoms without relying on drugs, hormones, or enduring severe side effects.
Researchers at ETH Zurich have managed to make sound waves travel only in one direction. In the future, this method could also be used in technical applications with electromagnetic waves.
The first crystal structure of an alternative DNA shape from the insulin gene has been revealed by a UCL-led research team.
Abbott (NYSE: ABT)+
today announced a major product launch, broadening the population that can utilize its continuous glucose monitoring (CGM) technology.
CENTER VALLEY, Pa., Sept. 5, 2024 /PRNewswire/ — Odin Medical Ltd., an Olympus Corporation company, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the first cloud-based Artificial Intelligence (AI) technology designed to assist gastroenterologists in detecting suspected colorectal polyps during colonoscopy procedures, the CADDIE™ computer-aided detection (CADe) device.
FREMONT, Calif., Sept. 5, 2024 /PRNewswire/ — THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced that its TMINI® Miniature Robotic System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use with the Persona® The Personalized Knee System® from Zimmer Biomet.
Fresenius Medical Care announced today that it launched the newest version of its home hemodialysis (HHD) machine, the NxStage Versi HD with GuideMe software.
The new MRI labelling extends the active scan time for Medtronic DBS systems.
PLANO, Texas, Sept. 4, 2024 /PRNewswire/ — Vesalio announces the U.S. commercialization of pVasc™ Thrombectomy System for non-surgically removing peripheral occlusions. pVasc targets the full range of embolisms from soft, acute clots to fibrin-rich, calcified ones, enabling a fast and safe removal. Its unique Drop Zone™ technology traps, retains and securely removes thrombus to restore flow in patients suffering from acute limb ischemia (ALI) and other conditions related to peripheral artery disease (PAD).